COMPANY

Jacaranda Biosciences, Inc.

HQ: South San Francisco, CA source · jacaranda-bio.com ↗ · West Coast

Keywords: small molecule

Location: South San Francisco, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.44M (SBIR Phase II 5R44DC020069-03, continuation, notice Jul 16, 2026). NIH RePORTER 5R44DC020069-03 (Jul 16, 2026)
Evidence (1 event)
- Jul 16, 2026 · NIH RePORTER 5R44DC020069-03
  Organization: JACARANDA BIOSCIENCES, INC.; City/State: SAN FRANCISCO, CA; Project number: 5R44DC020069-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-16; FY total cost (award amount): 1436795; Administering IC: National Institute on Deafness and Other Communication Disorders; Project title: eiF2B Activators to Treat Noise-Induced Hearing Loss; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Jul 16, 2026 Grant Government grant — SBIR: $1.44M (annual award, as published), announced Jul 16, 2026. Agency: NIH/NIDCD. Source: government award database. source ↗
May 1, 2025 Grant Government grant — SBIR: $1.55M (annual award, as published), announced May 1, 2025. Agency: NIH/NIDCD. Source: government award database. source ↗

Last 2 years.

Jul 16, 2026 Government grant — SBIR: $1.44M (annual award, as published), announced Jul 16, 2026. Agency: NIH/NIDCD. Source: government award database. source ↗
May 1, 2025 Government grant — SBIR: $1.55M (annual award, as published), announced May 1, 2025. Agency: NIH/NIDCD. Source: government award database. source ↗

Annual award amounts. Total $605K.

Jul 2, 2024 NIH award 1R43DC021398-01A1 FY2024: $304,762 awarded for that fiscal year; activity R43 (SBIR); PI CHOUCHANE, MALEK; recipient as written: JACARANDA BIOSCIENCES, INC., SAN FRANCISCO, CA. Development of UPR-Targeted T source ↗
Jun 21, 2022 NIH award 1R43DC020069-01A1 FY2022: $299,999 awarded for that fiscal year; activity R43 (SBIR); PI CHOUCHANE, MALEK; recipient as written: JACARANDA BIOSCIENCES, INC., SAN FRANCISCO, CA. eiF2B Activators to Treat Noi source ↗